SANA vs. CABA

In the year-to-date period, SANA achieves a 33.13% return, which is significantly higher than CABA's -17.62% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Sana Biotechnology, Inc. (SANA) and Cabaletta Bio, Inc. (CABA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current SANA Sharpe Ratio is -0.38, which is higher than the CABA Sharpe Ratio of -0.70. The chart below compares the historical Sharpe Ratios of SANA and CABA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither SANA nor CABA has paid dividends to shareholders.

The maximum SANA drawdown since its inception was -96.92%, roughly equal to the maximum CABA drawdown of -96.63%. Use the drawdown chart below to compare losses from any high point for SANA and CABA.

The current volatility for Sana Biotechnology, Inc. (SANA) is 32.99%, while Cabaletta Bio, Inc. (CABA) has a volatility of 40.97%. This indicates that SANA experiences smaller price fluctuations and is considered to be less risky than CABA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Sana Biotechnology, Inc. and Cabaletta Bio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.